UK MHRA will accept SUSARs in e-format only from 1 Sept
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency will as of 1 September 2010 accept only electronic submissions of reports of suspected unexpected serious adverse reactions (SUSARs) that occur during pharmaceutical clinical trials1.